Purisys - Crunchbase Company Profile & Funding

Q: Where is Purisys's headquarters?

Purisys is located in Athens, Attiki, Greece.

Overview

Purisys

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Purisys

CB Rank

281029

Purisys offers a broad lineup of manufacturing and personnel assets for the development, manufacture, and support of pharmaceutical APIs.

Acquired by

Siegfried Holding

Founded

obfuscation

Private

Athens, Attiki, Greece

51-100

purisys.com/

Information Technology

Manufacturing

Key People

James Mish: CEO and President
Past Role: Ashland, President - Consumer Specialties

Details

Operating Status

Closed

Company Type

For Profit

About the Company

Purisys offers a broad lineup of manufacturing and personnel assets for the development, manufacture, and support of pharmaceutical APIs and other chemical synthesis projects. Their flagship innovation center and manufacturing facility in Athens, GA (17,000 sq. ft.) offer decades of experience in complex high-barrier custom synthetic chemistry and

manufacture of pharmaceutical APIs as well as comprehensive controlled substance expertise.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Pharmaceutical-Grade Cannabinoids

Purified cannabinoids including cannabidiol (CBD) and over 50 other cannabinoids with ultra-low THC content for pharmaceutical and consumer product development.

Custom Small Molecule Chemistry Development and Manufacturing

Development and manufacturing services for small molecule APIs including high-potency, labile, and low-bioburden compounds with specialized chemical processing.